Baillie Gifford & CO Quidel Ortho Corp Call Options Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding QDEL
# of Institutions
293Shares Held
67.9MCall Options Held
337KPut Options Held
134K-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.4MShares$376 Million0.26% of portfolio
-
Carlyle Group Inc. Washington, DC8.26MShares$331 Million56.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$242 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$196 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.2MShares$168 Million5.33% of portfolio
About QuidelOrtho Corp
- Ticker QDEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 66,952,900
- Market Cap $2.68B
- Description
- QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...